Note s4
121 subscribers
329 photos
69 files
77 links
Download Telegram
Forwarded from ๐–ฌ๐–พ๐–ฝ๐—‚๐–ผ๐–บ๐—… ๐–ต๐–บ๐—…๐—…๐–พ๐—’แต‰โฟแตˆ-ยฒโฐยฒโถ (ุนูŽู€ู€ู„ูู€ู€ูŠ ุงู„ู€ู€ุฏู‘ูŽุฑูŽุงุฌูู€ู€ูŠ)
#๏ธโƒฃ ุฃู‡ู… ู…ุง ุจฺ†ุงุจุชุฑ 2๏ธโƒฃ ุชฺฏุฏุฑ ุชุนุชู…ุฏู‡ ูˆุชุนุชุจุฑู‡ ู…ุฑุงุฌุนุฉ ู„ู‚ุฑุงูŠุชูƒ

๐ŸŸกCardiac effect:
โœ…ุงูˆู„ ุดูŠ ุฐุงูƒุฑ ูˆูƒู„ุณุงุน ูŠุนูŠุฏู‡ุง ู…ู„ูŠู†ุง ู…ู†ู‡ุง ุงู†ูˆ ุงู„ุฃุณุจุฑูŠู† ูŠุดุชุบู„ ุนู„ู‰ COX1 ูˆูŠุญู…ูŠู†ูŠ ู…ู† CV event ุจุณุจุจ ุชุซุจูŠุท THXA2

โœ…ูˆุงู„ุฃุฏูˆูŠุฉ ุงู„ู„ูŠ ุชุดุชุบู„ ุนู„ู‰ COX2 ุนุฏู‡ุง ู…ุฎุงุทุฑ ุชุณูˆูŠ CV event ุฃุนู„ู‰ ุจุณุจุจ ุชุซุจูŠุท PGI2 ุงู„ู„ูŠ ู…ุณุคูˆู„ ุนู† ู…ู†ุน ุงู„ุฌู„ุทุงุช ูˆุชูˆุณุนุฉ ุงู„ุฃูˆุนูŠุฉ

๐Ÿ’™ูƒู„ NSAIDS ูŠุณูˆูˆู„ูŠ ู…ุฎุงุทุฑ CV ุนุฏุง ุงู„ุฃุณุจุฑูŠู†

โšก๏ธุงู„ู…ุฑูŠุถ ุงู„ู„ูŠ ุนู†ุฏู‡ ุฃู…ุฑุงุถ ู‚ู„ุจ ูˆูŠุฑูŠุฏ ูŠุงุฎุฐ NSAIDS ุฃุฃู…ู† ุดูŠ ู‡ูˆ Naproxen + ุงู„ุฃุณุจุฑูŠู† ุจุงู„ุฌุฑุน ุงู„ู‚ู„ูŠู„ุฉ ุงู„ุจู‚ูŠุฉ ู…ู…ู†ูˆุน
๐Ÿ˜€side effects:
โš ๏ธุงู„ุดุฎุต ุงู„ุนู†ุฏู‡ ุญุณุงุณูŠุฉ ุนุงู„ูŠุฉ ุชุฌุงู‡ ุงู„ุฃุณุจุฑูŠู† ู…ู…ู†ูˆุน ู†ู†ุทูŠ NSAIDS

๐ŸŸ Drug interaction:
ุœsalicylate (ูˆู…ู†ู‡ู… ุงู„ุฃุณุจุฑูŠู†) ูŠุฑุชุจุท ุจุงู„ุฃู„ุจูˆู…ูŠู† ุจู†ุณุจุฉ ูจู -ูฉู %
ูˆุนู†ุฏู‡ ู‚ุฏุฑุฉ ูŠุฒูŠุญ ุงู„ุฃุฏูˆูŠุฉ ุงู„ู„ูŠ ุชุฑุชุจุท ุจุงู„ุฃู„ุจูˆู…ูŠู† ู…ุซู„ :

phenytoin,warfarin,valproic acid

ุจุงู„ุชุงู„ูŠ ุชุฒุงุฏุงุฏ ู†ุณุจุชู‡ู… ุจุงู„ุฏู… ูˆุชุทู„ุน ุณุงูŠุฏ ุงููƒุช ู…ุงู„ุชู‡ู…
๐Ÿ›‘Toxicity:
๐Ÿ’กุฃุนุฑููˆ ุฃู† ุจุงู„ุฌุฑุน Mild salicylate ูŠุนู†ูŠ ู…ูˆ ุงู„ู‚ุงุชู„ุฉ ูŠุณู…ูˆู‡ salicylism ูˆุฃู‡ู… ุนุฑุถ ุจูŠู‡ุง ู‡ูˆ hyperventilation

๐Ÿ’กุจุณ ุจุงู„ู€ high dose of salicylate
ูŠุณูˆูŠู„ูŠ respiratory and metabolic acidosis

ุงู„ุฃุทูุงู„ ุฃูƒุซุฑ ุนุฑุถุฉ ู„ู„ุณู…ูŠุฉ ูˆุงู„ุฌุฑุน ุงู„ู‚ุงุชู„ุฉ 10g ู…ู† ุงู„ุฃุณุจุฑูŠู†
๐Ÿ”˜pregnancy:
ุฃุฃู…ู† ุดูŠ ู‡ูˆ Acetaminophen ูƒู€ ุฎุงูุถ ุญุฑุงุฑุฉ ูˆู…ุณูƒู†

โš ๏ธ ุฃุชุฌู†ุจ ุฅุนุทุงุก ุฃูŠ NSAIDS ููŠ ุงู„ุซู„ุซ ุงู„ุฃุฎูŠุฑ ู…ู† ุงู„ุญู…ู„ ู„ุฃู† ูŠุณูˆูŠ
Premature closure of ductus arteriousus


๐Ÿ›‘Selective COX2 Inhibitor:
ุฃู‡ู… ุฏูˆุงุก ู‡ูˆ celecoxib
ูˆูŠูƒูˆู† reversible Inhibitor
ูˆูŠุณุชุฎุฏู… ุจู€ RA,OA , Acute pain

ุชุนุฑู ุฃู†ูˆ ูŠุตูŠุฑ metabolism ุนู† ุทุฑูŠู‚ CYP2C9
ูˆ half-life ู…ุงู„ุชู‡ 11 ุณุงุนุฉ
ูŠู†ุทูŠ ู…ุฑุฉ ุงูˆ ู…ุฑุชูŠู† ุจุงู„ูŠูˆู…

๐Ÿ”ขุฅุฐุง ู…ุฑูŠุถ ุนู†ุฏู‡ ุถุนู ุจุงู„ูƒุจุฏ moderate ุจุณ ุฃุนุฏู„ ุงู„ุฌุฑุน
๐Ÿ”ขุฅุฐุง sever hepatic or Renal disease ู…ู…ู†ูˆุน ุฃู†ุทูŠ โš ๏ธ
ูŠุนุชุจุฑ ุฃู‚ู„ GIT side effects

ู…ู…ู†ูˆุน ุฃู†ุทูŠ ูˆูŠ ู…ุฑูŠุถ ุนู†ุฏู‡ ulcer ูˆูŠุงุฎุฐ ุฃุณุจุฑูŠู†โš ๏ธ

ู…ู…ูƒู† ูŠุฒุฏุงุฏ ุชุฑูƒูŠุฒู‡ ุจุงู„ุฏู… ุงุฐุง ุฎุฐุชู‡ ูˆูŠ fluconanzol ุงู„ู„ูŠ ูŠูƒูˆู† Inhibitor of CYP2C9
๐ŸŸกAcetaminophen :
โœ”๏ธู…ู‡ู… ุชุนุฑู ุงู†ูˆ ู‡ูˆ ูŠุซุจุท PG ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ุจ CNS
ู…ุงู„ู‡ ุนู„ุงู‚ุฉ ุจู€ Peripheral
ู„ุฐู„ูƒ ู‡ูˆ weak Anti-inflammatory ูˆู…ุง ูŠุนุชุจุฑูˆู‡ NSAIDS

โœ”๏ธุดุฎุต ุนู†ุฏู‡ ู…ุดุงูƒู„ ุจุงู„ู…ุนุฏุฉ ุฃูˆ ู…ุง ูŠุฑูŠุฏ ูŠุณุชุฎุฏู… NSAIDS ู†ู†ุทูŠ ู‡ุฐุง

โœ…"ูŠุนุชุจุฑ ุงู„ุฎูŠุงุฑ ุงู„ู…ูุถู„ ู„ู„ู…ุฑุถู‰ ุงู„ุนุฏู‡ู… ุนุฏูˆู‰ ููŠุฑูˆุณูŠุฉ ุจุชุณูƒูŠู† ุงู„ุฃู„ู… ูˆุฎูุถ ุงู„ุญุฑุงุฑุฉ"

๐Ÿค”ู‡ุฐุง Aceta ุฌุฒุก ู…ู†ู‡ ุจุงู„ู…ูŠุชุงุจูˆู„ุฒู… ูŠุชุญูˆู„ ุฅู„ู‰ NAPQI ู…ุงุฏุฉ ุณุงู…ุฉ ุชุฃุฐูŠ ุงู„ูƒุจุฏ
ุจุงู„ุญุงู„ุฉ ุงู„ุทุจูŠุนุฉ ุงู„ุฌุณู… ุนู†ุฏู‡ ุฌู„ูˆุชุงุซุงูŠูˆู† ูˆูŠุชุฎู„ุต ู…ู†ู‡ุง

๐Ÿค”ุจุงู„ุฌุฑุน ุงู„ุทุจูŠุนุฉ ู…ุงุจูŠ ู…ุดุงูƒู„
ุจุงู„ุฌุฑุน ุงู„ุนุงู„ูŠุฉ ุฑุงุญ ูŠุฎู„ุต ุฎุฒูŠู† ุฌู„ูˆุชุงุซุงูŠูˆู† ูˆูŠุณูˆูŠู„ูŠ Hepatic necrosis

๐Ÿค”ูˆุฎุงุตุฉ ุนู†ุฏ ุงู„ู†ุงุณ ุงู„ู„ูŠ ู‡ู…ู‡ :
hepatic disease,viral hepatitis,history of alcoholism
ุงู„ู„ูŠ ูŠุนุงู„ุฌู„ูŠ ุงู„ุณู…ูŠุฉ ู…ู‡ู… ุฌุฏุง
โœ…N-acetylcysteine


Traditional DMARDS:
ู†ูุณ ุงู„ุฃุดูŠุงุก ุงู„ุฎุฐู†ุงู‡ู† ุจุงู„ูƒู„ู†ูƒู„
ู…ุฌุฑุฏ ูŠุชุดุฎุต RA ุงุจุฏูŠ ุจูŠู‡ู† ูˆุงู„ู…ูุถู„ MTX

MTX:
ู‡ูˆ Folic acid antagonist
ู…ู…ูƒู† ูŠุนุงู„ุฌู„ูŠ psoriasis arthritis
ุงู„ูุนุงู„ูŠุฉ ู…ุงู„ุชู‡ ุชุญุชุงุฌ ูฃ-ูฆ ุฃุณุงุจูŠุน
ูŠู†ูˆุฎุฐ ู…ุฑุฉ ุจุงู„ุฃุณุจูˆุน

โœจุฃู‡ู… ุฃุนุฑุงุถู‡ ูŠุณูˆูŠ cirrhosis of liver , pneumonia like syndrome
ุญุชู‰ ูŠู‚ู„ู„ูˆู† ุงุนุฑุงุถู‡ ู…ู…ูƒู† ูŠู†ุทูˆู† leucovorin ุจุนุฏ MTX
ูˆู…ู…ูƒู† F.A supplements

โš ๏ธู…ู…ู†ูˆุน ุงู†ุทูŠ ู„ู„ุญุงู…ู„
hydroxychoroquine:
early,mild RA ูŠุณุชุฎุฏู… ููŠ
ูุนุงู„ูŠุชู‡ ูŠู„ุง ุชุจุฏูŠ ูฆุงุณุงุจูŠุน - ูฆ ุงุดู‡ุฑ
ูŠุณูˆูŠู„ูŠ ู…ุดุงูƒู„ ุจุงู„ุนูŠู† ุฃู‡ู…ู‡ุง
โœจirreversible retinal damage, corneal deposit
โœจูˆูƒุฐู„ูƒ skin discoloration, eruption
๏ปฟ
leflunomide:
๐Ÿ“ŽูŠุฑุชุจุท ุจู€ DHODH ุงู†ุฒูŠู… ูŠุฏุฎู„ ุจุชุตู†ูŠุน Pyrimdine
ู…ู† ูŠุฑุชุจุท ุจู‡ุฐุง ุงู„ุฃู†ุฒูŠู… ุฑุงุญ ูŠุซุจุทู‡ ูู€ ุฑุงุญ ูŠู‚ู„ู„ ุงู„ุฃู„ู…
ุญุชู‰ ู…ุชู†ุณู‰ ุงุชุฐูƒุฑ ูŠู‡ูˆุฏุง

ูŠู†ูˆุฎุฐ ูˆุญุฏู‡ ุงูˆ ุจุญุงู„ุฉ ู…ุง ุงุชุญู…ู„ ุงู„ู…ุฑูŠุถ MTX
ูˆู…ู…ูƒู† ูŠู†ูˆุฎุฐู† ุณูˆุฉ

โœจุงู‡ู… ุณุงูŠุฏ ุงููƒุช ู‡ูˆ Flue-like syndrome

โš ๏ธู…ู…ู†ูˆุน ุนู„ู‰ ุงู„ุญุงู…ู„
sulfasalazine:
๐Ÿ›‘ู…ุฏุฉ ูุนุงู„ูŠุชู‡ ุญุชู‰ ุชุจุฏูŠ ุชุญุชุงุฌ ูก-ูฃ ุงุดู‡ุฑ
โœจูŠุณูˆูŠู„ูŠ leoukpeina
ุณุงู„ุงุฒูŠู† = ุณุงู„ ุฏู…ู†ุง
Glucocorticoids:
๐ŸŸกูŠุณุชุฎุฏู… ูƒู€ ู…ุถุงุฏ ุงู„ุชู‡ุงุจ ุจู€ RA
ูˆุฌุณุฑ ู„ู„ู€ DMARDS ู„ุงู† ูŠุชุฃุฎุฑ ู…ูุนูˆู„ู‡ู†
ูŠุณุชุฎุฏู… ู„ูุชุฑุฉ ู‚ุตูŠุฑุฉ ูˆุจุฌุฑุน ู‚ุตูŠุฑุฉ

#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
Forwarded from ๐–ฌ๐–พ๐–ฝ๐—‚๐–ผ๐–บ๐—… ๐–ต๐–บ๐—…๐—…๐–พ๐—’แต‰โฟแตˆ-ยฒโฐยฒโถ (ุนูŽู€ู€ู„ูู€ู€ูŠ ุงู„ู€ู€ุฏู‘ูŽุฑูŽุงุฌูู€ู€ูŠ)
ู…ูˆุถูˆุน ู…ู‡ู… ูŠุฎุต ฺ†ุงุจุชุฑ RA ,GOUT
ุฃูƒุซุฑ ุงู„ุฃุฏูˆูŠุฉ ุชุญุชูˆูŠ ุนู„ู‰ mab


๐Ÿค”ุฒูŠู† ุชุนุงู„ูˆุง ุฎู„ ู†ูู‡ู… ุดุตุงูŠุฑ ุญุชู‰ ู…ู† ูŠุฌูŠ ุณุคุงู„ ูŠุฎุตู‡ู† ู…ุฑุงุญ ู†ุฎุฑุจุท ูˆู†ุฎุชุงุฑ ุตุญ

๐Ÿค”ุจุงู„ุจุฏุงูŠุฉ ูŠุญู‚ู†ูˆู† ุฌุณู… ุงู„ูุฃุฑ ุจู€ antigen ู…ุนูŠู† ุจุงู„ู†ู‡ุงูŠุฉ ุฑุงุญ ูŠุชูƒูˆู† antibody ุถุฏู‡ ูˆูŠุณู…ูˆู‡ Monoclonal Antibody ูˆู„ูŠุด mono ู„ุฃู† ุฃุฑูŠุฏู‡ ูŠุดุชุบู„ ูู‚ุท ุนู„ู‰ูฐ TNF ูˆู‚ุทุนุง ู„ูƒู„ ู‚ุงุนุฏุฉ ุดูˆุงุฐ ุจุณ ุงุญู†ุง ู†ุฑูŠุฏ ู†ูู‡ู… ุงู„ุณุงู„ูุฉ ูˆู‡ุงู„ูƒู„ุงู… ูŠู†ุทุจู‚ ุนู„ู‰ ุฃุบู„ุจ ุงู„ุฃุฏูˆูŠุฉ

ู‡ุงูŠ ูู‡ู…ู†ุงู‡ุง ุฒูŠู† ุงู„ู€ Suffix ุดู†ูˆ โ“
ู‡ู†ุฉ ูค ุฃู†ูˆุงุน ู…ุงูƒูˆ ุบูŠุฑู‡ู†

โบ๏ธุฅุฐุง ู…ุฃุฎูˆุฐ ู…ู† ุงู„ูุฃุฑ ูŠุนู†ูŠ 100% ูŠุณู…ูˆู‡
murine = suffix -omab


โบ๏ธ ุฅุฐุง ู…ุฃุฎูˆุฐ ู…ู† ุงู„ุฅู†ุณุงู† ุจู†ุณุจุฉ 65% ูˆุงู„ุจุงู‚ูŠ ุญูŠูˆุงู† ูŠุณู…ูˆู‡
chimeric = suffix -ximab


โบ๏ธ ุฅุฐุง ู…ุฃุฎูˆุฐ ู…ู† ุงู„ุฅู†ุณุงู† ุจู†ุณุจุฉ ุฃูƒุจุฑ ู…ู† 90% ูŠุณู…ูˆู‡
humanized = suffix -zumab


โบ๏ธ ุฅุฐุง ู…ุฃุฎูˆุฐ ู…ู† ุงู„ุฅู†ุณุงู† ุจู†ุณุจุฉ 100%
ูŠุณู…ูˆู‡

fully human = suffix -umab


Murine = oamb
Chimeric = ximab
Humanized = zumab
fully human = umab


๐Ÿ‘ู…ุนู‚ูˆู„ุฉ ุนู„ูŠ ูŠุฌู†ุŸ

ู…ุซู„ุง : ูŠุฌูŠุจู„ูƒ ูŠุงุฏูˆุฉ ู…ู† ุฐู† ูŠูƒูˆู† Chimeric antibody ูู…ู† ุฎู„ุงู„ ุงู„ู€ Suffix ุฑุงุญ ุชุฎุชุงุฑ ุงู„ู€ โœ…
ุฅุฐุง ู…ุชุนุฑูู‡ ุดู„ูˆู† ุชุฌุงูˆุจู‡๐Ÿ™ƒ

ุงู„ู‚ุตุฏ ู„ุฃู† ุฃูƒูˆ ุฃุฏูˆูŠุฉ ู…ู…ูŠุฒุฉ ุจู‡ูŠฺ† ุดูŠ ูู‡ุงู„ุณุจุจ ุณูˆูŠุช ู‡ุงู„ุจูˆุณุช

#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
Forwarded from ๐–ฌ๐–พ๐–ฝ๐—‚๐–ผ๐–บ๐—… ๐–ต๐–บ๐—…๐—…๐–พ๐—’แต‰โฟแตˆ-ยฒโฐยฒโถ (ุนูŽู€ู€ู„ูู€ู€ูŠ ุงู„ู€ู€ุฏู‘ูŽุฑูŽุงุฌูู€ู€ูŠ)
#๏ธโƒฃ ุฃู‡ู… ู…ุง ุจฺ†ุงุจุชุฑ 3๏ธโƒฃ ุชฺฏุฏุฑ ุชุนุชู…ุฏู‡ ูˆุชุนุชุจุฑู‡ ู…ุฑุงุฌุนุฉ ู„ู‚ุฑุงูŠุชูƒ
๐Ÿ”ก๐Ÿ” ๐Ÿ” ๐Ÿ” 1๏ธโƒฃ

Biologic DMARDs:
ุจูŠ ู†ูˆุนูŠู†
๐Ÿ˜€.Biologic TNF-ฮฑ
ู…ุฌู…ูˆุนุฉ ุจูƒู„ู…ุฉ ุณูŠุงุฌูŠ
Certolizumab,etanercept,adlimumab,Golimumab, Infliximab

๐Ÿ˜€.Non biolgic TNF-ฮฑ
ู…ุฌู…ูˆุนุฉ ุจูƒู„ู…ุฉ ART
Abatacept, Rituximab, Tocilizumab

๐ŸŸกุงู„ูุนุงู„ูŠุฉ ุชุณุชุบุฑู‚ ุฃุณุจูˆุนูŠู† ูŠู„ุง ุชุจุฏูŠ
๐ŸŸกุฃุณุชุฎุฏู…ู‡ู… ุจุญุฐุฑ ูˆูŠ ู…ุฑุถู‰ ูุดู„ ุงู„ู‚ู„ุจ
๐ŸŸกู…ู…ูƒู† ูŠุฒูŠุฏูˆู† ู…ุฎุงุทุฑ ุงู„ูƒุงู†ุณุฑ
๐ŸŸกูŠุณุชุฎุฏู…ูˆู‡ู… ุจุนุฏ ูุดู„ Traditional DMARDS
๐ŸŸ ู…ู…ูƒู† ูŠุณูˆูˆู† ุชู†ุดูŠุท ู„ู€ hepatitis B
ูˆูŠุฒูŠุฏู† ู…ุฎุงุทุฑ ุงู„ู€ infections ู…ุซู„ุง ูŠุณูˆู† TB
๐Ÿ›‘ู…ู…ู†ูˆุน ุฃู†ุทูŠ TNF-ฮฑ ูˆ non TNF-ฮฑ
๐Ÿ›‘ู…ู…ู†ูˆุน ุฃู†ุทูŠู‡ู… ูˆูŠ live vaccine
Adalimumab
ู…ุซู„ ู…ุง ุฐูƒุฑุช ุจุงู„ุจูˆุณุช ุงู„ู‚ุจู„ู‡ ู‡ูˆ
recombinant Monoclonal Antibody

๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ู‡ูˆ ู†ูุณู‡ ุฑุงุญ ูŠู†ุนุงุฏ ุจุฃุบู„ุจ ุงู„ุฃุฏูˆูŠุฉ ูŠุฑุชุจุท ุจู€ TNF-ฮฑ ูˆูŠู…ู†ุนู‡ ู…ู† ุงู„ุฅุฑุชุจุงุท ุจุฑุณุจุชุฑ ุงู„ุฎู„ูŠุฉ ุจุงู„ุชุงู„ูŠ ู…ุงูƒูˆ ุงุณุชุฌุงุจุฉ ู…ู†ุงุนูŠุฉ ุจุงู„ุชุงู„ูŠ ู‚ู„ ุงู„ุฅู„ุชู‡ุงุจ ูˆุบูŠุฑู‡

๐Ÿ”˜ูŠู†ูˆุฎุฐ SC ูƒู„ ุฃุณุจูˆุน ุฃูˆ ูƒู„ ุฃุณุจูˆุนูŠู†
๐Ÿ”˜ูˆุงู‡ู… A.E: ุœ Agranulocytosis
Certolizumab
๐Ÿ’กู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู…
ูŠุฏู…ุฌูˆู‡ ูˆูŠ polyethylene glycol ุจุนู…ู„ูŠุฉ peglation "ุนู„ู…ูˆุฏ ูŠุฒูŠุฏูˆู† bioavailability ูˆ half-life ู„ู„ูู‡ู…"

๐Ÿ”˜ ูŠู†ูˆุฎุฐ SC ูƒู„ ุฃุณุจูˆุนูŠู†
Etanercept
ู‡ูˆ
genetically engineered fusion protein
ู…ู‡ู… ุชุนุฑูู‡ ูŠุฌูŠุจู„ูƒ ู‡ุงู„ุดูŠ ูˆูŠูƒู„ูƒ ู…ู†ูˆ ุงู„ุฃุฏูˆูŠุฉ ุนู†ุฏู‡ ู‡ุงู„ู…ูŠุฒุฉ ุชุฎุชุงุฑู‡

๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ู†ูุณู‡
๐Ÿ”˜ ูŠู†ูˆุฎุฐ SC ูƒู„ ุฃุณุจูˆุน
Golimumab
๐Ÿ’ก ู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู…

๐Ÿ”˜ ูŠู†ูˆุฎุฐ SC ูƒู„ ุดู‡ุฑ ู…ุน Methotrexate
๐Ÿ”˜ู…ู…ูƒู† ูŠุฒูŠุฏ ุงู†ุฒูŠู…ุงุช ุงู„ูƒุจุฏ
Infliximab
ู‡ูˆ
Chimeric Monoclonal Antibody
ู…ู‡ู… ูŠุฌูŠุจ ู‡ุงู„ุดูŠ ูˆูŠุฑูŠุฏ ุงู„ุฅุณู… ูˆุดุฑุญุชู‡ ุจุงู„ุจูˆุณุช ุดู„ูˆู† ุตุงุฑ

๐Ÿ’กู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู…
โš ๏ธ ู…ุง ูŠู†ุทูŠ ูˆุญุฏู‡ ู„ุฃู† ูŠุตูŠุฑู„ู‡ anti-infliximab Antibody ู„ุฐู„ูƒ ูŠู†ุทูˆู† ูˆูŠุงู‡ Methotrexate
๐Ÿ”˜ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ูจ ุฃุณุงุจูŠุน "ุดู‡ุฑูŠู†"
Abatacept
๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ูŠุชู†ุงูุณ ู…ุน CD28 ุนู„ู‰ ุงู„ุฅุฑุชุจุงุท ุจุงู„ุฑุณุจุชุฑุงุช ุงู„ู…ูˆุฌูˆุฏุฉ ุนู„ู‰ ุณุทุญ Macrophage ูˆ B cells

ุจุงู„ุชุงู„ูŠ ุฑุงุญ ูŠู…ู†ุน T cell ูŠุตูŠุฑู„ู‡ุง ุงุฑุชุจุงุท ุจุงู„ุฑุณุจุชุฑ ูŠุนู†ูŠ ู…ุง ุฑุงุญ ุชุชุญูุฒ ูุฑุงุญ ูŠู‚ู„ู„ ู…ู† ุงู„ุฅู„ุชู‡ุงุจ

๐Ÿ”˜ ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ูค ุฃุณุงุจูŠุน
๐Ÿ”˜ุฃู‡ู… upper respiratory infection: A.E
Rituximab
ู‡ูˆ ุฃูŠุถู‹ุง ูŠูƒูˆู†
Chimeric murine/human Monoclonal Antibody
ู…ู‡ู…ู…ู…ู…ู…

๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ูŠุฑุชุจุท ุจู€ CD20 ุงู„ู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ B cells
ุจุงู„ุชุงู„ูŠ ูŠู‚ู„ู„ ุฎุฑูˆุฌ B cell

๐Ÿ”˜ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ูกูฆ-ูขูค ุฃุณุจูˆุน
๐Ÿ”˜ู…ู…ูƒู† ูŠุณูˆูŠ ุญุณุงุณูŠุฉ ููŠู†ุทูˆู† ูƒูˆุฑุชูŠุฒูˆู†ุŒ ุจุฑุงุณูŠุชูˆู„ุŒู…ุถุงุฏ ู‡ุณุชุงู…ูŠู† ู‚ุจู„ ูƒู„ ุฌุฑุนุฉ
ูˆุฃู‡ู… A.E: ูŠุณูˆูŠ hypotension ูˆุฎุงุตุฉ ุนู†ุฏ ุฃูˆู„ ุฃุณุชุฎุฏุงู…
Tocilizumab & Sarilumab

๐Ÿ’ก ุงู„ู…ูŠูƒุงู†ุฒู… ูŠุฑุชุจุทูˆู† ุจุงู„ุฑุณุจุชุฑ ู…ุงู„ IL-6 ุจุงู„ุชุงู„ูŠ ูŠู…ู†ุนูˆู† ุฎุฑูˆุฌ IL-6 ุจุงู„ุชุงู„ูŠ ูŠู‚ู„ ุงู„ุฅู„ุชู‡ุงุจ

ู…ู‡ู… ุงุชุฐูƒุฑ ุฐูˆู„ ุงู„ุซู†ูŠู† ุฃุณู…ุงุฆู‡ู… ุจูŠู‡ุง il ูŠุนู†ูŠ ูŠุดุชุบู„ูˆู† ุนู„ู‰ IL
ูˆุงูˆู„ ุญุฑููŠู† ู…ู† ุฃุณู…ุงุฆู‡ู… ุชู†ุทูŠ ูƒู„ู…ุฉ ุณุช ูŠุนู†ูŠ 6
ููŠุดุชุบู„ูˆู† ุนู„ู‰ IL-6


๐Ÿ”˜ูŠู†ูˆุฎุฐู† ุซู†ูŠู†ู‡ู… SC ูƒู„ ุฃุณุจูˆุนูŠู†
ูˆู…ุฑุงุช Tocilizumab ูŠู†ูˆุฎุฐ IV ูƒู„ ูค ุฃุณุงุจูŠุน
๐Ÿ”˜ุฃู‡ู… A.E: ูŠุณูˆูˆู† hyperlipidemia , Hypertension
Tofacitinib
๐Ÿ’กู‡ูˆ Janus-Kinase Inhibitors
ูŠุณุชุฎุฏู… ู„ุนู„ุงุฌ moderate-severe RA
ู„ู„ู…ุฑูŠุถ ุงู„ู„ูŠ ู…ุง ุชุญุณู‘ู† ุฃูˆ ู…ุง ุฃุชุญู…ู„ MTX

๐Ÿ“Œุญุชู‰ ุฃุณุชุฎุฏู…ู‡ ู„ุงุฒู… HB ุฃูƒุซุฑ ู…ู† 9g/dl
ู„ุฃู† ู…ู…ูƒู† ูŠุณูˆูŠ anemia ู„ุฐู„ูƒ ู„ุงุฒู… ุฃุฑุงู‚ุจ ุงู„ู€HB

โœ”๏ธ ูŠููุถู„ ุฃุฎู„ูŠ ุขุฎุฑ ุฃุฎุชูŠุงุฑ ู„ุฃู† ู…ู…ูƒู† ูŠุณูˆูŠู„ูŠ malignancy ูˆุฎุงุตุฉ ุงุฐุง ุงู„ู…ุฑูŠุถ ู…ุง ุงุณุชูุงุฏ ุงูˆ ู…ุง ุงุชุญู…ู„ ุจู‚ูŠุฉ ุงู„ุฃุฏูˆูŠุฉ
๏ปฟ
โฌ‡๏ธTreatment of Gout โฌ‡๏ธ

๐ŸŸกู‡ุฏููŠ ู…ู† ุงู„ุนู„ุงุฌ ุฃู†ุฒู„ ุงู„ู€ uric acid ุงู‚ู„ ู…ู†
<6mg/dl
ูˆุงู„ุนู„ุงุฌ ุฃู…ุง ุฃูˆู‚ู ุชุตู†ูŠุน ุฃูˆ ุฃุฒูŠุฏ ุทุฑุญ U.A

ุจุนู„ุงุฌ ุงู„ู†ูˆุจุงุช Acut gout ู‡ู†ุฉ ุชู„ุงุซุฉ CNC
Corticosteroid, NSAIDS, Colchicine

ูˆุชุฌูŠ ุงู„ู†ูˆุจุฉ ู„ุนุฏุฉ ุฃุณุจุงุจ ู…ู†ู‡ุง
๐Ÿ”ข. ูŠุดุฑุจ ูƒุญูˆู„ ู‡ูˆุงูŠ
๐Ÿ”ข. ูŠุงูƒู„ ูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ู…ู† purine
๐Ÿ”ข. ู…ุฑุถ ูƒู„ูˆูŠ

ูˆู…ู…ูƒู† ูŠู†ุทูˆู† ุนู„ุงุฌ ูˆู‚ุงุฆูŠ ุญุชู‰ ู…ูŠุตูŠุฑ ุนู†ุฏูŠ ู†ูˆุจุฉ ูˆุฎุงุตุฉ ุงุฐุง ูƒุงู† ุนู†ุฏูŠ ุฃูƒุซุฑ ู…ู† ู†ูˆุจุชูŠู† ุจุงู„ุณู†ุฉ ุงูˆ ู…ุฑุถ ูƒู„ูˆูŠ ุงูˆ ุญุตูˆู‰ ุจุงู„ูƒู„ู‰ ุงูˆ tophi

๐Ÿ””ู‡ุณุฉ ู†ุณูˆู„ู ุจุงู„ุนู„ุงุฌ ูˆุฎุงุตุฉ Chronic Gout
ู‡ู†ุฉ ฺฏุฑูˆุจูŠู† ุฃู…ุง ุฃุฒูŠุฏ ุงู„ุทุฑุญ ุฃูˆ ุงู‚ู„ู„ ุงู„ุฅู†ุชุงุฌ ู…ุงู„ uric acid
๐Ÿ˜€.xanthaine oxidase Inhibitor ( allopurinol, febuxostat)
First line urate lowering agent

๐Ÿ˜„.Uricosuric agent (Probencid)
ู‡ุงูŠ ุชุฒูŠุฏ ุงู„ุทุฑุญ ู…ุงู„ u.a ูˆุชููŠุฏ ููŠ ุญุงู„ุฉ ุงู„ู…ุฑูŠุถ ู…ุง ุงุณุชุฌุงุจ ู„ู„ู€ ุงู„ฺฏุฑูˆุจ ุงู„ุฃูˆู„ ุฃูˆ ู…ุง ุงุชุญู…ู„ู‡ู…

๐Ÿ”– ูˆุงูˆู„ ู…ุง ุฃุจุฏูŠ ุฃุณุชุฎุฏุงู… ูˆุงุญุฏ ู…ู† ุฐู† ู„ุงุฒู… ุงู†ุทูŠ ูˆูŠุงู‡ู… Anti-inflammatory ุญุชู‰ ุงู…ู†ุน Acut gout ูˆูŠุณุชู…ุฑ ุนู„ูŠู‡ ุงู‚ู„ ุดูŠ ูฆ ุฃุดู‡ุฑ
Colchicine
ู‡ูˆ ู„ุง ู…ุณูƒู† ูˆู„ุง uricosuric ู‡ูˆ ู…ุฌุฑุฏ ูŠุฎูู ุงู„ุฃู„ู… ุงู„ู„ูŠ ูŠุตูŠุฑ ูˆูŠ Acute gout

๐Ÿ’กูŠุฑุชุจุท ุจุงู„ู€ tubulin,microtubulin ูˆูŠุณูˆูŠ depolymerization
ูˆูŠุฎุฑุจุท ุดุบู„ ุงู„ุฎู„ูŠุฉ ููŠู…ู†ุน neutrophils ุชุฑูˆุญ ู„ู„ู…ูุตู„ ุงู„ู…ุตุงุจ ูˆุชุณูˆูŠู„ูŠ ุงู„ุชู‡ุงุจ
ูˆูƒุฐู„ูƒ ูŠู…ู†ุน ุฃู†ู‚ุณุงู… ุงู„ุฎู„ูŠุฉ ู„ุฃู† ูŠุฑุชุจุท ุจู€ mitotic spindle

โœ”๏ธ ูŠุฎูู ุงู„ุฃู„ู… ุฎู„ุงู„ ูกูขุณ ู…ู† ุงู„ุฅุตุงุจุฉ
โœ…ู…ุง ูŠุตูŠุฑ ู†ู†ุทูŠ ุจุนุฏ ูฃูฆุณ ู…ู† ุงู„ุฅุตุงุจุฉ
๐Ÿ“ŒูŠุตูŠุฑู„ู‡ metabolism ุนู† ุทุฑูŠู‚ CYP3A4
๐Ÿ”˜ุฃู‡ู… A.E : ุœmyopathy, aplastic anemia

โš ๏ธู…ู…ู†ูˆุน ุฃู†ุทูŠ ู„ู„ุญุงู…ู„
โšก๏ธุฃุนุฏู„ ุงู„ุฌุฑุนุฉ ุงุฐุง ุฃุฎุฐู‡ ูˆูŠ CYP3A4 Inhibitors ุฃูˆ p-glycoprotein
ุฃูˆ ู…ุฑุถู‰ ุงู„ูƒู„ู‰
ูŠุชุจุน.....

#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
Forwarded from ๐–ฌ๐–พ๐–ฝ๐—‚๐–ผ๐–บ๐—… ๐–ต๐–บ๐—…๐—…๐–พ๐—’แต‰โฟแตˆ-ยฒโฐยฒโถ (ุนูŽู€ู€ู„ูู€ู€ูŠ ุงู„ู€ู€ุฏู‘ูŽุฑูŽุงุฌูู€ู€ูŠ)
๐Ÿ” ๐Ÿ” ๐Ÿ” ๐Ÿ” 2๏ธโƒฃ

Allopurinol
๐Ÿ’กูŠุฑุชุจุท ุจู€ oxidase enzyme ููŠู…ู†ุน ุขุฎุฑ ุฎุทูˆุชูŠู† ู…ู† ุชูƒูˆู† Uric acid

๐Ÿ˜ูุนุงู„ ุจุนู„ุงุฌ gout , ูˆ hyperuricemia ุงู„ู„ูŠ ุชุฌูŠ ู†ุชูŠุฌุฉ malignancy ุงูˆ Renal disease

โœ”๏ธูŠุชุญูˆู„ ุงู„ู‰ metabolite ูŠุณู…ูˆู‡ alloxanthine (oxypurinol)
ูˆ ุงู„ู€ half-life ู…ุงู„ุชู‡ู… ู…ู† ูกูฅ-ูกูจ ุณุงุนุฉ
ูŠู†ูˆุฎุฐ ู…ุฑุฉ ุจุงู„ูŠูˆู…
โœ…ุฃุนุฏู„ ุงู„ุฌุฑุน ููŠ ุญุงู„ุฉ ูƒุงู† GFR ุฃู‚ู„ ู…ู† 30
๐Ÿ”˜ุฃู‡ู… A.E : ุœskin rash
Febuxostat
ู†ูุณ ุฃุฎูˆู‡ ูŠู†ูˆุฎุฐ ุงูˆุฑู„ ุจุณ ุงู„ุญุณุงุณูŠุฉ ุจุงู„ุฌู„ุฏ ุฃู‚ู„

โš ๏ธุฃุณุชุฎุฏู…ู‡ ุจุญุฐุฑ ูˆูŠ ู…ุฑุถู‰ ุงู„ู‚ู„ุจ
ู„ุฃู† ูŠุณูˆูŠ ู…ุดุงูƒู„ ุจุงู„ู‚ู„ุจ ุนูƒุณ ุฃุฎูˆู‡ ุงู„ููˆฺฏ allopurinol
Probencid
oral uricosuric acid
๐Ÿ’กูŠุฒูŠุฏ ุทุฑุญ uric acid ู…ู† ุฎู„ุงู„ ุชุซุจูŠุท
urate - anion exchange in proximal tubule

โš ๏ธู…ู…ู†ูˆุน ุฃุณุชุฎุฏู…ู‡ ุฅุฐุง creatinine clearance ุฃู‚ู„ ู…ู† 50ml/min
๐Ÿ”˜ุฃู‡ู… A.E : ุœdermatologic reaction
Pegloticase
ู‡ูˆ ู…ุตู†ุน ูˆู…ุดุงุจู‡ ู„ุฃู†ุฒูŠู… ุฅุณู…ู‡ urate oxidase ุงูˆ uricase
ู…ู† ุฅุณู…ู‡ ุชุนุฑู ุฅุณู… ุงู„ุฃู†ุฒูŠู…

ูŠุญูˆู„ ุงู„ูŠูˆุฑูƒ ุงู„ู‰ allntoin ู…ุงุฏุฉ ุชุฐูˆุจ ุจุงู„ู…ูŠ ูˆุชุทู„ุน ุจุงู„ูƒู„ู‰

โœ”๏ธูŠุณุชุฎุฏู… ููŠ ุญุงู„ ุนุฏู… ุงู„ุงุณุชุฌุงุจุฉ ู„ุฃุฏูˆูŠุฉ first line
๐Ÿ”˜ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ุฃุณุจูˆุนูŠู†
๐Ÿ”˜ู…ู…ูƒู† ูŠุณูˆูŠ ุญุณุงุณูŠุฉ ููŠู†ุทูˆู† ู…ุถุงุฏ ู‡ุณุชุงู…ูŠู† ูˆ ูƒูˆุฑุชูŠุฒูˆู† ู‚ุจู„ ู…ุง ูŠุณุชุฎุฏู…ูˆู‡
๏ปฟ
#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
Forwarded from ๐–ฌ๐–พ๐–ฝ๐—‚๐–ผ๐–บ๐—… ๐–ต๐–บ๐—…๐—…๐–พ๐—’แต‰โฟแตˆ-ยฒโฐยฒโถ (ุนูŽู€ู€ู„ูู€ู€ูŠ ุงู„ู€ู€ุฏู‘ูŽุฑูŽุงุฌูู€ู€ูŠ)
โญ•๏ธุœ
ุฃุฏูˆูŠุฉ RA ูˆุดฺฏุฏ ู†ุณุชุฎุฏู…ู‡ู… ู…ู‡ู…ุงุงุงุงุงุช ุฌุฏู‹ุง

Adalimumab โžก๏ธ weekly
or every other week

Certolizumab โžก๏ธ every 2 w

Etanercept โžก๏ธ once weekly

Golimumab โžก๏ธ once a month

Infliximab โžก๏ธ every 8 w

Abatacept โžก๏ธ every 4 w

Rituximab โžก๏ธ every 16โ€“24 w

Tocilizumab โžก๏ธ every 2 w
also IV every 4 w

Sarilumab โžก๏ธ every 2 w

#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
Forwarded from ๐–ฌ๐–พ๐–ฝ๐—‚๐–ผ๐–บ๐—… ๐–ต๐–บ๐—…๐—…๐–พ๐—’แต‰โฟแตˆ-ยฒโฐยฒโถ (ุนูŽู€ู€ู„ูู€ู€ูŠ ุงู„ู€ู€ุฏู‘ูŽุฑูŽุงุฌูู€ู€ูŠ)
โญ•๏ธุœ
ุฃุฏูˆูŠุฉ bisphosphonates ู„ุนู„ุงุฌ OP ูˆุฃู‡ู… ุงู„ู…ู„ุงุญุธุงุช ุนู„ูŠู‡ุง

"Alendronate"
if oral tab โฉ daily or weekly
if effervescent โฉ weekly

"Ibandronate"
if oral tab โฉ daily or monthly
if intravenous โฉ every 3 month

"Risedronate"
if oral tab โฉ daily,weekly, or monthly
if oral delayed-release tab โฉ weekly

"Zoledronic acid"
intravenous โฉ yearly

โšก๏ธ ูƒู„ู‡ู… ู„ุงุฒู… ุฃุฎุฐู‡ู… ูˆูŠ ู…ุงุก ุทุจูŠุนูŠ ู„ุง ุญู„ูŠุจ ูˆู„ุง ูƒู‡ูˆุฉ ูˆู„ุง ุนุตูŠุฑ ..
โบ๏ธู„ุงุฒู… ูŠูƒูˆู† ุงู„ู…ุงุก ุญูˆุงู„ูŠ ูฆ-ูจ ุงูˆู†ุต ูŠุนู†ูŠ ุจุญุฏูˆุฏ 180-240 ู…ู„
โบ๏ธูŠู†ูˆุฎุฐูˆู† ู‚ุจู„ ุงู„ุฃูƒู„ ูˆุงู„ุฃุฏูˆูŠุฉ ุจู†ุต ุณุงุนุฉ (ุนุฏุง Ibandronate ุจุณุงุนุฉ)
โบ๏ธูŠุญุชุงุฌ ุชูƒุนุฏ ุงูˆ ุชูˆูƒู ู…ุฏุฉ ู†ุต ุณุงุนุฉ ู„ูƒู„ ุงู„ุฃุฏูˆูŠุฉ(ุนุฏุง Ibandronate ูŠุญุชุงุฌ ุณุงุนุฉ)

โœจุฅุณุชุซู†ุงุก ุจุณูŠุท ูู‚ุท
Risedronate delayed release tab
๐Ÿ”ขูŠุญุชุงุฌ ุฃู‚ู„ ุดูŠ ูค ุงูˆู†ุต ู…ู† ุงู„ู…ุงุก ูŠุนู†ูŠ 120 ู…ู„ ุชู‚ุฑูŠุจุง
๐Ÿ”ขูˆูŠู†ูˆุฎุฐ ุจุนุฏ ูˆุฌุจุฉ ุงู„ูุทูˆุฑ ู…ุจุงุดุฑุฉ

1 ounce = 30ml


#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
Forwarded from ๐–ฌ๐–พ๐–ฝ๐—‚๐–ผ๐–บ๐—… ๐–ต๐–บ๐—…๐—…๐–พ๐—’แต‰โฟแตˆ-ยฒโฐยฒโถ (ุนูŽู€ู€ู„ูู€ู€ูŠ ุงู„ู€ู€ุฏู‘ูŽุฑูŽุงุฌูู€ู€ูŠ)
#๏ธโƒฃุฃู‡ู… ู…ุง ุจฺ†ุงุจุชุฑ 4๏ธโƒฃ ุชฺฏุฏุฑ ุชุนุชู…ุฏู‡ ูˆุชุนุชุจุฑู‡ ู…ุฑุงุฌุนุฉ ู„ู‚ุฑุงูŠุชูƒ ๐Ÿ’€๐Ÿ’€๐Ÿ’€๐Ÿ’€

ุจุงู„ุจุฏุงูŠุฉ ุฐุงูƒุฑ ุชุนุฑูŠูุงุช ู…ู…ูƒู† ูŠุฌู† ูู„ุงุฒู… ุชุนุฑูู‡ู†
Osteoporosis
ูŠุชู…ูŠุฒ ุงู†ูˆ ูƒุชู„ุฉ ุงู„ุนุธู… ุชู‚ู„ ูˆูŠูƒูˆู† ุงู„ู‡ูŠูƒู„ ุงู„ุนุธู…ูŠ ู‡ุด ุจุงู„ุชุงู„ูŠ ูŠูƒูˆู† ุนุฑุถุฉ ู„ู„ูƒุณุฑ ูˆูƒุฐู„ูƒ ู…ุฑุงุญ ุฃฺฏุฏุฑ ุงุชุญุฑูƒ
ูˆูŠุตูŠุฑ ุนู†ุฏ ุงู„ู†ุณุงุก ุจุนุฏ ุณู† ุงู„ูŠุฃุณ
ูˆุงู„ุฃุดุฎุงุต ุงู„ูƒุจุงุฑ ุจุงู„ุนู…ุฑ ุจูƒู„ุง ุงู„ุฌู†ุณูŠู†
๏ปฟ
Paget disease
ูŠุชู…ูŠุฒ ุงู†ูˆ ุงู„ุนุธู… ุฑุงุญ ูŠูƒูˆู† ุบูŠุฑ ู…ู†ุธู… ูˆู…ุชูˆุณุน ูˆุดูƒู„ู‡ ู…ุฎุฑุจุท
ูˆูŠุฎุชู„ู ุนู† OP ุงู†ูˆ ูŠุตูŠุจ ุนุธุงู… ู‚ู„ูŠู„ุฉ
ูˆูŠูƒูˆู† ุงู„ู…ุฑูŠุถ ูŠุนุงู†ูŠ ู…ู† ุฃู„ู… ูˆุชุดูˆู‡ุงุช ูˆูƒุณูˆุฑ
๏ปฟ
Osteomalacia
ู‡ูˆ ุชู„ูŠู† ุงู„ุนุธู… ูŠุนู†ูŠ ุงู„ุนุธู… ูŠุตูŠุฑ ู„ูŠู†
ูˆุณุจุจู‡ ู†ู‚ุต ููŠุชุงู…ูŠู† D
ูˆู‡ูˆ ู‡ุฐุง ู†ูุณู‡ ุงู„ู„ูŠ ูŠุตูŠุฑ ุนู†ุฏ ุงู„ุฃุทูุงู„ ูˆูŠุณู…ูˆู‡ ุงู„ูƒุณุงุญ rickets
๏ปฟ
prevention of OP
ุญุชู‰ ุฃู‚ู„ู„ ุงุญุชู…ุงู„ูŠุฉ ุฎุณุงุฑุฉ ุงู„ุนุธู… ุนู†ุฏ ุงู„ู†ุณุงุก ุจุนุฏ ุณู† ุงู„ูŠุฃุณ
๐Ÿ›‘ู„ุงุฒู… ุชุงูƒู„ ุจุงู„ูˆุฌุจุฉ ุชุญุชูˆูŠ vit. D,Ca ุจุดูƒู„ ูƒุงููŠ
๐Ÿ›‘ุชุณูˆูŠ ุชู…ุงุฑูŠู†
๐Ÿ›‘ุชูˆู‚ู ุชุฏุฎูŠู†
๐Ÿ›‘ุชู‚ู„ู„ ุงุณุชู‡ู„ุงูƒ ูƒุญูˆู„
ุงู„ุนู†ุฏู‡ ู†ู‚ุต ูƒุงู„ุณูŠูˆู… ู…ู…ูƒู† ูŠู†ุทูˆู‡:

๐Ÿ˜€Calcium carbonate
ูˆู‡ูˆ ุงู„ุดุงุฆุน ูˆู…ูˆ ุบุงู„ูŠ ูˆูŠุญุชูˆูŠ ุนู„ู‰
40% ca element
ูˆู„ุงุฒู… ูŠู†ูˆุฎุฐ ูˆูŠ ุงู„ุฃูƒู„ ุนู„ู…ูˆุฏ ุงู„ุฃู…ุชุตุงุต

๐Ÿ˜„calcium citrate
21% ca element
ูˆุนุงุฏูŠ ู‚ุจู„ ุงูˆ ุจุนุฏ ุงู„ุฃูƒู„
โš ๏ธู…ู…ู†ูˆุน ูŠู†ูˆุฎุฐ ุงู„ูƒุงู„ุณูŠูˆู… ูˆูŠ
iron , thyroid replacement, fluoroquinolone , Tetracycline

ุงู„ุนู†ุฏู‡ ู†ู‚ุต vit.D ูŠู†ุทูˆู‡:
ergocalciferol (D2)
cholecalciferol (D3)


Treatment of OP
ุฃูˆู„ ุนุงุฆู„ุฉ ูˆู‡ู…ุฉ
๐Ÿ’€bisphosphonates

Risedronate,Alendronate,Zoledronic acid
ู…ุฌู…ูˆุนูŠู† ุจูƒู…ุฉ ุฃุฑุฒ
preferred agent for treatment of postmenopausal osteoporosis

ู‡ุฐู† ุงู„ุฃุฏูˆูŠุฉ ูˆุจู‚ูŠุฉ ุงู„ุนุงุฆู„ุฉ ู…ุซู„ :
etidronate, Ibandronate, pamidroante, tiludronate
ุชุณุชุฎุฏู… ููŠ ุนู„ุงุฌ :
OP, Paget disease, bone metastasis, hypercalcemia of malignancy

๐Ÿ’กุœM.O.A : ุชุฑุชุจุท ุจู€ hydroxyapitate crystals ุงู„ู…ูˆุฌูˆุฏ ุจุงู„ุนุธุงู… ูˆุชู‚ู„ู„ ู…ู† osteoclast ุจุงู„ุชุงู„ูŠ ุชู‚ู„ู„ ู…ู† bone loss ูˆ fructure

โš ๏ธู…ู…ู†ูˆุน ุฃู†ุทูŠ ู„ู…ุฑุถู‰ ุงู„ูƒู„ู‰ ู„ุฃู† ู‡ูˆ ูŠู†ุทุฑุญ ุนู† ุทุฑูŠู‚ ุงู„ูƒู„ู‰
โœ”๏ธ ุงู„ู…ุง ูŠฺฏุฏุฑ ูŠุงุฎุฐ ุงู„ู€ oral ุฃู†ุทูŠ IV ุณูˆุงุก
Zoledronic acid , Ibandronate are alternative
๐Ÿ”˜ุฃู‡ู… A.E : ูŠุณูˆูŠ ู‡ูˆุงูŠ ู…ุดุงูƒู„ ุจุงู„ู…ุนุฏุฉ ู…ุซู„
esophagitis, esophageal ulcer
ูˆุญุชู‰ ุฃุญู„ู‡ุง ุงูˆ ุงู‚ู„ู„ู‡ุง ุงู†ุตุญ ุงู„ู…ุฑูŠุถ ูŠุจู‚ู‰ ูˆุงูƒู ู…ู† ูŠุงุฎุฐ ู‡ุงูŠ ุงู„ุฃุฏูˆูŠุฉ

โค๏ธ ู†ู†ุตุญ ุงู„ู…ุฑูŠุถ ุจุฃุฎุฐ ุฑุงุญุฉ ู…ู† ุงู„ุฃุฏูˆูŠุฉ durg holiday ูˆุฎุงุตุฉ
ุจุนุฏ ูฅ ุณู†ูŠู† ู…ู† ุงุณุชุฎุฏุงู… ุงู„ู€ oral
ุงูˆ ูฃ ุณู†ูŠู† ู…ู† ุงุณุชุฎุฏุงู… Zoledronic
ู„ุฃู† ุงู„ุฃุณุชุฎุฏุงู… ุงู„ู…ุทูˆู„ ู…ู…ูƒู† ูŠุณูˆูŠู„ูŠ ุชู†ุฎุฑ ุจุงู„ููƒ ุงูˆ ูƒุณุฑ ุจุงู„ุญูˆุถ ูˆู‡ุฐู† ู†ุงุฏุฑุงุช ุจุณ ู…ู…ูƒู† ูŠุตูŠุฑู†

๐Ÿ’€Denosumab
๐Ÿ’กุœM.O.A : ูŠุฑุชุจุท ุจุฑุณุชุจุฑ ุฅุณู…ู‡ ุฑุงู†ูƒู„ RANKL
receptor activator of nuclear factor kappa-b ligand
ูˆูŠุซุจุท osteoclast ุชูƒูˆู†ู‘ู‹ุง ูˆูˆุธูŠูุฉู‹
โœ”๏ธู…ูุถู„ ู„ู„ู€
postmenopausal Osteoporosis in women at high risk of fracture
๐Ÿ”˜ูŠุนุทู‰ SC ูƒู„ ูฆ ุฃุดู‡ุฑ
โœ… ูŠุนุชุจุฑ first line ู…ุซู„ ู…ฺฏู„ู†ุง ุจุนู„ุงุฌ PM-OP with high risk of fracture
๐Ÿ”˜ุฃู‡ู… A.E : ุœhypocalcemia
๏ปฟ
๐Ÿ’€Parathyroid agents
ุฏูˆุงุฆูŠู†
Teriparatide like PTH
Abaloparatide like PTHrP

๐Ÿ’กุœM.O.A: ู‡ุงูŠ ุงู„ุฃุฏูˆูŠุฉ ุชุฎุชู„ู ุนู† ุงู„ุจู‚ูŠุฉ
ู‡ูˆ ุงู†ูˆ ุชุดุชุบู„ ุนู„ู‰ ุชูƒูˆู† ุงู„ุนุธุงู… bone formation ุจุงู„ุชุงู„ูŠ ุชุญูุฒ osteoblast ูˆุชุฒูŠุฏ bone strength
๐Ÿ”˜ุฃู‡ู… A.E : ุœhypercalcemia, orthoststic hypotension
ูˆูƒุฐู„ูƒ osteosarcoma in rats๐Ÿฆซ

โœ”๏ธู„ุง ูŠู†ุตุญ ุจุงู„ุฃุณุชุฎุฏุงู… ู„ุฃูƒุซุฑ ู…ู† ุณู†ุชูŠู†

๐Ÿ’€Selective estrogen receptor modulator
ุงู„ุฃุณุชุฑูˆุฌูŠู† ูŠู„ุนุจ ุฏูˆุฑ ู…ู‡ู… ุจู€ ุชุซุจูŠุท osteoclast ูˆุชู†ุดูŠุท osteoblast ูู‚ู„ุฉ ู‡ุฐุง ุงู„ู‡ุฑู…ูˆู† ุนู†ุฏ ุงู„ู†ุณุงุก ูˆุฎุงุตุฉ Postmenopausal ูŠุคุฏูŠ ุงู„ู‰ ุฒูŠุงุฏุฉ osteoclast ูˆู…ู…ูƒู† ูŠุคุฏูŠ ุงู„ู‰ bone loss ุงุฐุง ู…ุง ุชุนุงู„ุฌุช

โบ๏ธู…ู…ูƒู† ุฃู†ุทูŠ estrogen supplements ุจุณ ู…ุง ุจูŠ ููˆุงุฆุฏ ู„ุฃู† ูŠุดุชุบู„ ุนู„ู‰ ูƒู„ ุงู„ุฑุณุจุชุฑุงุช ุงู„ู…ูˆุฌูˆุฏุฉ ุจุงู„ุฌุณู… ููŠุญูุฒ ุฑุณุจุชุฑุงุช bone,breast,uterus
ูู…ู…ูƒู† ูŠุณูˆูŠู„ูŠ ูƒุงู†ุณุฑ ู„ุฐู„ูƒ ุบูŠุฑ ู…ูุถู„
โœ”๏ธRaloxifene
ู‡ูˆ SERM
๐Ÿ’กุœM.O.A : ูŠุดุชุบู„ agonist ุนู„ู‰ ุงู„ุนุธู…
ูˆ antagonist ุนู„ู‰ breast, uterus
ุจุงู„ุชุงู„ูŠ ู…ุง ูŠุณูˆูŠู„ูŠ ูƒุงู†ุณุฑ
โบ๏ธูŠุนุชุจุฑ ุจุฏูŠู„ ููŠ ุญุงู„ุฉ ูุดู„ ุจู‚ูŠุฉ ุงู„ุฃุฏูˆูŠุฉ ู…ุซู„ bis ุงูˆ deno
๐Ÿ”˜ุฃู‡ู… A.E :ุœ hot flash, leg cramp , venous thromboembolism
๏ปฟ
๐Ÿ’€ Calcitonin
โบ๏ธุœ ูŠุนุงู„ุฌ OP ู„ู„ู†ุณุงุก ุงู„ู„ูŠ ุตุงุฑู„ู‡ุง ุฃู‚ู„ ุดูŠ ูฅ ุณู†ูˆุงุช ู…ู† ูˆุตู„ุช Postmenopausal
โบ๏ธุœ ูŠู‚ู„ู„ bone resorption
โบ๏ธ ุœุฃู‚ู„ ูุนุงู„ูŠุฉ ู…ู† ุจู‚ูŠุฉ ุงู„ุฃุฏูˆูŠุฉ
โบ๏ธ ุœุบูŠุฑ ู…ูˆุตู‰ ุจู‡ ู„ูุชุฑุฉ ุทูˆูŠู„ุฉ
๐Ÿ”˜ุœ ูŠูˆุฎุฐ intranasal ุจุฎุงุฎ ุจุงู„ุฃู†ู
๐Ÿ”˜ุœ ุฃู‡ู… A.E : ุœrhinitis ูˆ nasal symptoms
ุงูƒูŠุฏ ู„ุฃู† ุขู†ู‡ ุฌุงูŠ ุฃุฎุฐู‡ ุนู† ุทุฑูŠู‚ ุงู„ุฃู†ู
๏ปฟ
๐Ÿ”ฅุฅุฐุง ุฃุฌุงูƒ ูƒูŠุณ ุนู† OP ูˆุฑุงุฏ 1st line ฺฏุจู„ ููƒุฑ ุจุงู„ู€ bis
ุจุณ ุฅุฐุง ฺ†ุงู† ุนู†ุฏู‡ ูƒุณุฑ ุฃูˆ ู‡ุณุชุฑูŠ ูƒุณูˆุฑ ููƒุฑ ุจู€ Denosumab ุงูˆ Parathyroid agents


#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
Forwarded from ๐–ฌ๐–พ๐–ฝ๐—‚๐–ผ๐–บ๐—… ๐–ต๐–บ๐—…๐—…๐–พ๐—’แต‰โฟแตˆ-ยฒโฐยฒโถ (ุนูŽู€ู€ู„ูู€ู€ูŠ ุงู„ู€ู€ุฏู‘ูŽุฑูŽุงุฌูู€ู€ูŠ)
๐Ÿ”ค๐Ÿ”ค๐Ÿ”ค๐Ÿ”ค๐Ÿ”ค๐Ÿ”ค๐Ÿ”ค๐Ÿ”ค

๐Ÿ’กInsulins

1๏ธโƒฃShort acting

โบ๏ธRegular insulin

2๏ธโƒฃRapid acting

โบ๏ธLispro
โบ๏ธAspart
โบ๏ธGlulisine
ู‚ุงุนุฏุฉ: ุชุฎูŠู„ู‡ู… ู„ุฒูƒุฉ ุจุณุงุน ู†ุฎู„ูŠู‡ุง
l,as,g

3๏ธโƒฃIntermediate acting insulin

โบ๏ธNeutral prostamine Hagedorn (NPH)
ู‚ุงุนุฏุฉ: ุจูŠ N ูŠุนู†ูŠ Not speed,Not solw

4๏ธโƒฃLong acting insulin

โบ๏ธDetemir
โบ๏ธDegludec
โบ๏ธGlargine
ู‚ุงุนุฏุฉ: ุชุฎูŠู„ู‡ู… determine ุงูˆ delayed ูŠุนู†ูŠ ูŠุทูˆู„ูˆู†

5๏ธโƒฃInsulin Combination

โบ๏ธ70% NPH โž• 30% Regular
โบ๏ธ50% NPH โž• 50% Regular
ู‚ุงุนุฏุฉ : ู„ุงุฒู… NPH ู…ูˆุฌูˆุฏ

๐Ÿ’กSynthetic amylin analog

โบ๏ธPramilintide
ู‚ุงุนุฏุฉ: ูŠุญุชูˆูŠ ุนู„ู‰ amilin ูŠุดุจู‡ amylin

๐Ÿ’กGLP1 receptor agonist

โบ๏ธAlbiglutide
โบ๏ธDulaglutide
โบ๏ธExenatide
โบ๏ธLiraglutide
โบ๏ธLixisenatide
โบ๏ธSemaglutide
ู‚ุงุนุฏุฉ: ูƒู„ู‡ู… ูŠู†ุชู‡ูˆู† ุจู€ glutide ุนุฏุง
ู„ูƒุฒุฒ lixis ูˆุงุณุชุงู† extan
ุชุฎูŠู„ู‡ุง ู‡ูŠฺ†
GLP1 = Glu-Tide

๐Ÿ’กOral hypoglycemic drugs

1โƒฃSulfonylureas

๐Ÿ”˜Glipizide
๐Ÿ”˜Glyburide
๐Ÿ”˜Glimepiride
ู‚ุงุนุฏุฉ: ูƒู„ู‡ู… ูŠู†ุชู‡ูˆู† ุจู€ ide
ุชุฐูƒุฑ ุจุฃูŠุฏูŠ ุงุฎู„ูŠ ุจูŠู‡ุง ุงู„ุณู„ููˆู† ู…ุงู„ ู†ุฑูƒู„ูŠุฉ

2โƒฃGlinides

๐Ÿ”˜Repaglinide
๐Ÿ”˜Nateglinide
ู‚ุงุนุฏุฉ: ูƒู„ู‡ู… ูŠู†ุชู‡ูˆู† ุจู€ glinide
ู†ูุณ ุงู„ุนุงุฆู„ุฉ

3โƒฃBiguanides

๐Ÿ”˜Meformin
ู‚ุงุนุฏุฉ: ู‡ูˆ ู‡ุฐุง ูˆุญุฏู‡ ูˆูŠูƒูˆู† big ุงู„ุนุงุฆู„ุฉ

4โƒฃThiazolidinediones

๐Ÿ”˜Pioglitazone
๐Ÿ”˜Rosiglitazone
ู‚ุงุนุฏุฉ : ูƒู„ู‡ู… ูŠู†ุชู‡ูˆู† ุจู€ glitazone
ูˆูŠุญุชูˆูˆู† ุนู„ู‰ azo ูŠุนู†ูŠ ู…ู† ุนุงุฆู„ุฉ Thiazo

5โƒฃAlpha -glucosidase inhibitors

๐Ÿ”˜Acarbose
๐Ÿ”˜Miglitol
ู‚ุงุนุฏุฉ : ุชุฎู„ูŠู‡ู… "ูƒุงุฑุจูˆู‡ูŠุฏุฑุงุช" ููŠุดุชุบู„ูˆู† ุนู„ู‰ ุงู†ุฒูŠู… ุงู„ูƒู„ูˆูƒูˆุณุฏูŠุฒ

6โƒฃDPP4 inhibitors

๐Ÿ”˜Alogliptin
๐Ÿ”˜Linagliptin
๐Ÿ”˜Saxagliptin
๐Ÿ”˜Sitaglitptin
ู‚ุงุนุฏุฉ: ูƒู„ู‡ู… ูŠู†ุชู‡ูˆู† ุจู€ gliptin
ุฑุงุญ ู†ุณูˆูŠ ูุฏูŠูˆ glip ู„ู„ู€ ุฏุจุจ DPP

7โƒฃSGLT2 inhibitors

๐Ÿ”˜Canagliflozin
๐Ÿ”˜Dapagliflozin
๐Ÿ”˜Empagliflozin
๐Ÿ”˜Ertugliflozin
ู‚ุงุนุฏุฉ: ูƒู„ู‡ู… ูŠู†ุชู‡ูˆู† ุจู€ gliflozin
ุจูŠู‡ู… flo ูŠุนู†ูŠ ูŠุทู„ุนูˆู† ุงู„ุณูƒุฑ ู…ุน ุงู„ุจูˆู„

8โƒฃDopamine agonist 

๐Ÿ”˜Bromocriptin
ู‚ุงุนุฏุฉ: ุงู„ุฏูˆุจุงู…ูŠู† ู„ู„ุฏู…ุงุบ
ู‡ุณุฉ ู…ุงู„ ูƒุฑูŠุจ ูˆููˆูƒุงู‡ ู…ุจุฑูˆุด

9โƒฃBile acid sequestrant

๐Ÿ”˜Colesvelam
ู‚ุงุนุฏุฉ: ู…ู† ุฅุณู…ู‡ cole ูŠุนู†ูŠ ุชุฎูŠู„ู‡ ูƒูˆู„ุณุชุฑูˆู„ ููŠุฑุชุจุท ุจุงู„ู‚ู†ูˆุงุช ุงู„ุตูุฑุงูˆูŠุฉ

#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
DM.pdf
178.3 KB
ู…ูู„ุฎุต ู„ู…ุฑุงุฌุนุฉ ุงู‡ู… ู…ุนู„ูˆู…ุงุช DM โœ…

#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
Forwarded from ๐–ฌ๐–พ๐–ฝ๐—‚๐–ผ๐–บ๐—… ๐–ต๐–บ๐—…๐—…๐–พ๐—’แต‰โฟแตˆ-ยฒโฐยฒโถ (ุนูŽู€ู€ู„ูู€ู€ูŠ ุงู„ู€ู€ุฏู‘ูŽุฑูŽุงุฌูู€ู€ูŠ)
๐Ÿ”ฅุญุฑุงู… ุนู„ู‰ ุดุจุงุจูƒ ู…ุง ุชุญูุธ ู‡ุงู„ุจูˆุณุช

very ร—10ยนโตโฐ important

1๏ธโƒฃCisplatin
๐ŸŸ Ototoxicity
๐ŸŸ Nephrotoxdcity
๐ŸŸ Nausea/vomiting

2๏ธโƒฃ Cytarabine
๐ŸŸกChemical conjunctivitis

3๏ธโƒฃ bleomycin / busulfan
๐Ÿ›‘pulmonary toxicity

4๏ธโƒฃ cyclophosphamide/ifosfamide
๐Ÿ”ตHemorrhaglc cystitis

5๏ธโƒฃ doxorubicin/daunorubicin
๐Ÿ›‘Cardiotoxicity

6๏ธโƒฃ oxyaliplatin/vincristine/taxine
๐Ÿ›‘peripheral neuropathy

7๏ธโƒฃ Irinotecan
๐Ÿ”˜diarrhea

#phamra_theroy@MedicalValley2
Please open Telegram to view this post
VIEW IN TELEGRAM
Note s4 pinned ยซ#๏ธโƒฃ ุฃู‡ู… ู…ุง ุจฺ†ุงุจุชุฑ 1๏ธโƒฃ ุชฺฏุฏุฑ ุชุนุชู…ุฏู‡ ูˆุชุนุชุจุฑู‡ ู…ุฑุงุฌุนุฉ ู„ู‚ุฑุงูŠุชูƒ ู…ู„ุงุญุธุฉ : NSAIDs ฺ†ุงุจุชุฑ ู…ู‡ู… ูˆุฏุฑุฌุชู‡ ุฒูŠู†ุฉ ูุญุงูˆู„ ู„ุง ุชุชุฑูƒู‡ ุฑุงุญ ุฃุญุงูˆู„ ุฃฺฏู„ูƒ ุดู†ูˆ ุชู‚ุฑุฉ ูˆุดู†ูˆ ุงู„ู…ู‡ู… ูˆุฑุงุญ ุฃฺฏู„ูƒ ุงุฑุฌุน ู„ู„ู…ู„ุฒู…ุฉ ุชู‚ุฑุฉ ู‡ุงู„ุดูŠ ู„ุฃู† ุงู„ุฑุณุงู„ุฉ ุชุตูŠุฑ ุทูˆูŠู„ุฉ ๐Ÿ›‘prostaglandin: "ูŠุณู…ูˆู‡ุง ุจุนุถ ุงู„ุฃุญูŠุงู† eicosanoids" ู…ู‡ู…โ€ฆยป
ฺชู„ ู…ุง ุชุฑุฌูˆู‡ู ุขุชู ุŒ ุฅู†ูŽู‘ ุฎูŠุฑูŽ ุงู„ู„ู‡ู ู…ู‚ุจู„๐Ÿฆ‹โœจ๏ธ
Forwarded from Note s4
ุงู„ side effects ุงู„ู…ู…ูŠุฒุฉ ู…ู† NSAID ุฅู„ู‰ Diabetes


Salicylism (mild toxicity of salicylate ) โ†’mental confusion , dizziness,
tinnitus, hyperventilation confusion ,



Severe toxicity of salicylate โ†’ Restlessness, delirium, hallucinations, convulsions, coma , respiratory and metabolic acidosis, respiratory failure




Methotrexate โ†’ acute pneumonia-like syndrome, Cytopenias , mucusal ulceration



Hydroxychloroquine โ†’ skin discolouration+ eruption



Leflunomide โ†’flu-like syndrome , weight loss , alopecia, hypokalemia



Sulfasalazine โ†’ leukopenia



Adalimumab โ†’ agranulocytosis


Abatacept โ†’ upper respiratory infection


Tocilizumab+ sarilumab โ†’ hyperlipidemia, neutropenia, hypertension



Colchicine โ†’ myopathy, neutropenia, aplastic anemia, {alopecia( also hydroxychloroquine)}



Biosphonates โ†’ osteonecrosis of jaw , atypical femur fracture ,



Denosumab โ†’ Hypocalcemia , also osteonecrosis of jaw , atypical femur fracture ,


Relaxofene โ†’ leg cramps, venous thromboembolism



Teriparatide , abaloparide โ†’ hypercalcaemia , orthostatic hypotension, osteosarcoma

https://t.me/Quizpharmcy

#Antiinflammation
#DMARDs
ู‡ูˆ ุงูƒูˆ ู†ู…ุท ุฏูŠุฌูŠุจูˆู† ู…ู†ู‡ ุงู„ูŠ ู‡ูˆ ูŠุฐูƒุฑูˆู† ุฌู…ู„ุฉ least likely ูŠุนู†ูŠ ู…ูŠุตูŠุฑ ู†ู†ุทูŠ
ุงูˆ ูŠูƒูˆู„ poor choice
ุฐู†ูŠ ูƒู„ู…ุชูŠู† ุจุฏู„ except ุงูˆ ุจุฏู„ should not give
ูŠุงุฑุจ ู†ุฌุงูˆุจ๐Ÿ˜ช
โค2
Note s4 pinned ยซ#ุตู†ุงุนูŠุฉ #filtartion #mixing #milling #sterile #sterilization #clarification #dryingยป
DRYING


ุดู†ูˆ ุงู„ุทุฑู‚ ุงู„ูŠ ุชูƒูˆู† Non-thermal ุงุฌูู ุจูŠู‡ุง ุงู„ู…ุงุฏุฉ ุŸ

expression - extraction- absorption-adsorption-desiccation


๐Ÿ’ Psychrometry determines = vapor concentration and carrying capacity of gas

๐Ÿ’ water vapor in a gas = humidity of the gas.

๐Ÿ’ CDE curve = saturation humidity = 100% RH

๐Ÿ’ FCA = 78 grains water/pound dry air

๐Ÿ’ Dew point C (60ยฐF) = temperature at which air becomes completely saturated with moisture

๐Ÿ’ GK = 50% relative humidity

๐Ÿ’ wet โ€“bulb temperature= equilibrium of heat transfer between air-liquid.

๐Ÿ’ Wet-bulb temperature= measured by thermometer (bulb is covered by wick saturated with water).

๐Ÿ’ Dry-bulb temperature= actual air temperature= measured by ordinary thermometer.

๐Ÿ’ Theory of dry = heat and mass transfer

๐Ÿ’ driving force for heat transfer = temperature differential.


๐Ÿ’ rate of evaporation = dW/dฯด=q/ฦ›

๐Ÿ’ rate of diffusion = dW/dฯด=k A(Hs-Hg)

๐Ÿ’ rate of heat transfer include = convection,
radiation and conduction

ุดู„ูˆู† ุงุณุฑุน ู…ุนุฏู„ ุงู„ุชุฌููŠู ุŸ

- convection= increasing the air flow rate and by raising the inlet air temperature.

- rate of radiation

-rate of conduction = increased by reducing the thickness

-Increasing the air velocity= increasing
the coefficient of mass

- Dehumidifying= increase the humidity differential = low relative humidity



ุดู„ูˆู† ุงุนุจุฑ ุนู† ุงู„ุฑุทูˆุจุฉ ุจุงู„ู…ุงุฏุฉ ุงู„ุตู„ุจุฉ ุŸ

ุฌ/ wet weight or dry-weight.

๐Ÿ’ LOD = wet weight * 100%

๐Ÿ’ MC = dry-weight * 100%

๐Ÿ’ initial = A-B , Heating rate=Cooling rate

๐Ÿ’ temperature stabilized = B= moisture film at the surface

๐Ÿ’ constant rate= BC , Evaporation rate= Diffusion rate

๐Ÿ’ critical moisture content= C = no more moisture is replaced and dry spot appears = Drying rate falls off


๐Ÿ’ first falling rate = C-D= Drying falls steadily

๐Ÿ’ second critical point=D= Drying rate
depends on diffusion rate

๐Ÿ’ second falling rate = D-E = drying rate falls rapidly.

๐Ÿ’ equilibrium moisture = E + drying rate=Zero + temperature and moisture content remain constant.


๐Ÿ’ crystalline solids = easily drying

๐Ÿ’ amorphous solids = difficult drying

๐Ÿ’ Dryers can be classified based on = method of heat transfer or method of sample
handling


ู„ูŠุด turbo ูŠูƒูˆู† ุงุณุฑุน ู…ู† tunnel ุŸ

ุฌ/ ู„ุงู† ุฑุงุญ ูŠุชุนุฑุถ ุจุดูƒู„ continuous ู„ู„ู‡ูˆุงุก


ูŠุงุทุฑูŠู‚ุฉ ุชูƒูˆู† partially suspended in the gas stream ุŸ

Fluidized

ูŠุงุทุฑูŠู‚ุฉ ุงุณุชุนู…ู„ู‡ุง ู„ู„ granular ุŸ

Fluidized

ู„ูŠุด granules ุจุทุฑูŠู‚ุฉ Fluidized ุชูƒูˆู† ู„ุงุฌุงูุฉ ูˆู„ุงุฑุทุจุฉ ุŸ

ุฌ/ ุนู„ู…ูˆุฏ ุงุชุฌู†ุจ cracking

ูŠุงุทุฑูŠู‚ุฉ ุชู†ุทูŠู†ูŠ ุฌุฒูŠุฆุงุช ุชูƒูˆู† spherical free- flowing ุŸ

Fluidized

ู„ูŠุด ุทุฑูŠู‚ุฉ Fluidized ุชู†ุทูŠู†ูŠ ู…ุนุฏู„ ุชุฌููŠู ุนุงู„ูŠ ูˆุซุงุจุช ุŸ

ู„ุงู† ูƒู„ ุงุณุทุญ ุงู„ุฌุฒูŠุฆุงุช ุฑุงุญ ุชูƒูˆู† ู…ุนุฑุถุฉ ู„ู„ุญุฑุงุฑุฉ ุจุดูƒู„ ู…ูˆุญุฏ ูŠุนู†ูŠ ู…ุญุงุทุฉ ุจุงู„ุญุฑุงุฑุฉ ุจูƒู„ ู…ูƒุงู†


ูŠุงุทุฑูŠู‚ุฉ ุงุณุชุฎุฏู…ู‡ุง ู„ู„ fluidุŸ

Spray

ูŠุงุทุฑูŠู‚ุฉ ุชููŠุฏู†ูŠ ู„ู„ู…ูˆุงุฏ ุงู„ุญุณุงุณุฉ ู„ู„ุญุฑุงุฑุฉ ูˆุชููŠุฏู†ูŠ ุจุตู†ุงุนุฉ tab ูˆ capsule ุŸ

Spray

ูŠุงุทุฑูŠู‚ุฉ ุงุณุชุฎุฏู…ู‡ุง ุญุชู‰ ุงุฎููŠ ุงู„ุทุนู… ุงู„ู…ุฑ ูˆ ุงุตู†ุน sustained-release ุŸ

Chilling spray

ูŠุงุทุฑูŠู‚ุฉ ุงุณุชุฎุฏู… ุจูŠู‡ุง ุณุฑุนุฉ ูˆุญุฑุงุฑุฉ ุนุงู„ูŠุฉ ุญูŠู„ ูˆุชูƒูˆู† short-time ุŸ

Flash Dryers


ูŠุงุทุฑูŠู‚ุฉ ุงุณุชุฎุฏู… ุจูŠู‡ุง lyophilization, or sublimation ุŸ

Freeze

ูŠุงุทุฑูŠู‚ุฉ ุงุณุชุฎุฏู…ู‡ุง ู„ู„ุจู„ุงุฒู…ุง ูˆุงู„ุฏู… ูˆุงู„ู„ู‚ุงุญุงุชุŸ

Freeze

ู„ูŠุด ุงุณูˆูŠ Pre-freezing ุŸ

ุญุชู‰ ุงุชุฌู†ุจ ุชูƒูˆูŠู† ุงู„ุฑุบูˆู‡

ู„ูŠุด ุงุณุชุนู…ู„ Rotary pumps ุจุทุฑูŠู‚ุฉ ุงู„ูุฑูŠุฒ ุŸ

ุนู„ู…ูˆ ุงู‚ู„ู„ ุงู„ุถุบุท

ูŠุงุณุชูŠุฌ ุงุญูˆู„ ุจูŠู‡ุง latent heat ุจุงู„ุชุณุงู…ูŠ ุฅู„ู‰ ุจุฎุงุฑ ูˆุงุชุฎู„ุต ู…ู† unbound waterุŸ

Primary drying

ูŠุงุณุชูŠุฌ ุงุชุฎู„ุต ุจูŠ ู…ู† bound water ุŸ

Secondary drying


ูŠุงุทุฑูŠู‚ุฉ ุงุณุชุฎุฏู… ุจูŠู‡ุง energy ูˆุชุชุญูˆู„ ุฅู„ู‰ internal heat ุŸ

Microwave

ูŠุงุทุฑูŠู‚ุฉ ุชู†ุทูŠู†ูŠ rapid heat transfer ูˆ rapid drying ุŸ

Microwave

ูŠุงุทุฑูŠู‚ุฉ ุชูƒูˆู† ุจูŠู‡ุง ุงู„ุฑุทูˆุจุฉ vapor ุจุฏู„ liquid ุŸ

Microwave

ุนู„ู‰ ุดู†ูˆ ู…ุงูŠุนุชู…ุฏ MicrowaveุŸ


mass concentration gradients or on slow liquid diffusion rate
Membrane Ultrafiltration section of Chapter 4: Clarification:


---

Membrane Ultrafiltration โ€“ MCQs

Q1: What type of separation does ultrafiltration perform?
A. Thermal separation
B. Molecular separation
C. Density separation
D. Electrical separation
Answer: B


---

Q2: Ultrafiltration membranes primarily retain:
A. Ions
B. Particulates
C. Macromolecules
D. Water
Answer: C


---

Q3: Which of the following passes through an ultrafiltration membrane?
A. Proteins
B. Macromolecules
C. Solvent and small molecules
D. Bacteria
Answer: C


---

Q4: What is a key difference between microfiltration and ultrafiltration?
A. Ultrafiltration is less selective
B. Microfiltration removes molecules
C. Ultrafiltration removes bacteria
D. Microfiltration removes particulates, ultrafiltration separates molecules
Answer: D


---

Q5: The separation ability of ultrafiltration membranes is determined by:
A. Filter thickness
B. Surface tension
C. Molecular weight cut-off
D. Pore density
Answer: C


---

Q6: Which of the following is not retained by an ultrafiltration membrane?
A. Immunoglobulins
B. Proteins
C. Viruses
D. Water
Answer: D


---

Q7: Which method is used to apply pressure in ultrafiltration?
A. Centrifugal force
B. Hydraulic press
C. External pump pressure
D. Thermal gradient
Answer: C


---

Q8: What is one of the most important pharmaceutical uses of ultrafiltration?
A. Water purification
B. Removal of color
C. Removal of pyrogens
D. Extraction of oils
Answer: C


---

Q9: Ultrafiltration is particularly suitable for:
A. Non-polar solvents
B. Heat-labile products
C. Dry powders
D. Oil-based formulations
Answer: B


---

Q10: In pharmaceutical applications, ultrafiltration is used to recover:
A. Alcohols and acids
B. Sugars and salts
C. Antibiotics and hormones
D. Glass beads and pigments
Answer: C


---

Q11: Ultrafiltration can separate two solutes based on:
A. Their melting point
B. Their boiling point
C. Their molecular size
D. Their solubility in water
Answer: C


---

Q12: Which of the following is not an application of ultrafiltration?
A. Separation of cells
B. Clarification of solutions
C. Removal of particles >10 ฮผm
D. Recovery of vitamins
Answer: C



---

Q14: Which type of molecules are held back by ultrafiltration membranes?
A. Small solvent molecules
B. Gases
C. Macromolecules
D. Ions
Answer: C


---

Q15: What is a common use of ultrafiltration before using conventional recovery techniques?
A. Increase pressure
B. Remove pyrogens
C. Remove low-molecular-weight contaminants
D. Add preservatives
Answer: b
#clarification
โคโ€๐Ÿ”ฅ2